3^rd International Conference on HIV/AIDS, STDs & STIs November 29-30,2015 Hilton Atlanta Airport, Atlanta, USA

OMICS International is pleased to invite the contributors across the globe to its premier  3^rd  International conference on HIV/AIDS, STDs & STIs-2015 which is slated at Atlanta, USA, Nov -30 – Dec-02, 2015

The 3^rd International conference on HIV/AIDS, STDs & STIs-2015 is the leading HIV Conference in USA. STD-AIDS 2015 program will showcase new scientific knowledge and offers a platform for professionals and community members to engage in a structured dialogue on the major issues. The collective goal will be to share scientific discoveries and clinical care on HIV and retroviral diseases, HIV diagnosis and therapy that would include various methods to techniques to diagnose HIV, HIV drug discovery, viral and bacterial STDs, STIs, like Herpes, Syphilis, HPV etc., strategies for HIV and STDs prevention, bioethics etc. As HIV/AIDS is an alarming concern throughout the world, STD-AIDS-2015 will mainly focus on issues like Primary HIV Infection, Transmission and Eradication Issues apart from this HIV Co-infection, HIV Current pharmaceutical design would cover the experimental drugs developed. STD-AIDS-2015, lays perfect platform for physicians, nurses/nurse-practitioners, pharmacists, psychologists, behavioral researchers, Health care professionals, social scientists, epidemiologists, social workers, AIDS service organization (ASO) staff, students, Academicians and professionals working in the field of HIV medicine.

Awareness and knowledge on HIV/AIDS, STDs and STIs:

Attempts are made to understand the awareness, knowledge and risk to HIV/AIDS, STDS & STIS among youths, married women etc.   HIV/AIDS awareness and educational programs are having a limited effect especially among the married women who do not perceive of the risk of STD/HIV from their spouses and requires urgent preventive measures through innovative approaches that focus on female controlled methods. It is of critical importance that family planning and STD/HIV, Health promotion, Hygiene promotion, Prevention education and Prevention programs be integrated.

There are various organizations working to spread awareness, some of them are INTERNATIONAL AIDS SOCIETY, KAISER FAMILY FOUNDATION, UNAIDS, WORLD HEALTH ORGANIZATION etc.

Some of the awareness programs are organized every year on Dec-01 on the AIDS day, various countries host their events to raise hands and fight towards HIV/AIDS.

For more scientific sessions visit:http://hiv-aids-std.conferenceseries.com/call-for-abstracts.php 

Viral, Bacterial, Fungal STDs:

In general, viral infections can involve many different parts of the body at the same time. Viral STDs, especially herpes, hepatitis B and C, and HIV infections, usually persist for life. Antiviral drugs can control but not yet cure all of these infections, except hepatitis C, which can be cured in some people after prolonged treatment. Bacterial STDs are curable through treatment with antibiotics. Curable, that is, as long as you see a health-care provider, get tested and treated, follow through on all the medication, avoid sexual contact until cured, and make sure your sexual partner(s) get tested and treatment as well. Bacterial STD List: Chancroid, Chlamydia,Gonorrhea (‘The Clap’),Lymphogranuloma Venereum (LGV),Mycoplasma Genitalium,Nongonococcal Urethritis (NGU).Pelvic Inflammatory Disease (PID),Syphilis,Vaginitis (BV, Yeast, Etc.) – Can also be viral and parasitic

Fungal Infections are not technically STIs, a yeast infection can be passed through sexual contact in rare circumstances. Vaginal yeast infection, A vaginal yeast infection is a common fungal infection caused by overgrowth of Candida, naturally occurring yeast.

Since 1998, the Centers for Disease Control and Prevention released guidelines for the treatment of sexually transmitted diseases. Several treatment advances have been made since the previous guidelines were published.

Three antiviral medications have been shown to provide clinical benefit in the treatment of genital herpes: acyclovir, valacyclovir and famciclovir. Parenteral penicillin continues to be the drug of choice for treatment of all stages of syphilis

HIV AIDS in Africa:

HIV/AIDS is a major public health concern and cause of death in many parts of Africa, roughly 25 million people were living with HIV, accounting for nearly 70 percent of the global total. In the same year, there were an estimated 1.6 million new HIV infections and 1.2 million AIDS-related deaths. Southern Africa exhibits pandemic-level HIV infection rates, with extreme levels in the countries of Botswana, Lesotho, South Africa, Namibia, Zimbabwe, Swaziland, and Zambia. North Africa has one of the lowest HIV prevalence rates worldwide. HIV infection rates in East and Central Africa are generally moderate to high. Uganda has experienced a slow decline in HIV rates, decreasing the rate in school girls in Central African Republic from 10.6% to a stable 6.5 – 7.0% from 1997 to 2001 respectively. HIV and AIDS were unfamiliar to the area of southern Africa as recently as the mid 1980s; now, it is the most affected area worldwide. Of the eleven countries in South Africa (Angola, Namibia, Zambia, Zimbabwe, Botswana, Malawi, Mozambique, South Africa, Lesotho, Swaziland, Madagascar) at least 7 are deemed to exceed 15% for infection rate.

HIV AIDS prevention and Treatment:

While 1.1 million Americans currently live with HIV/AIDS, the incurable virus is no longer a quick death sentence and has become a chronic, manageable condition. Most people who have become recently infected with HIV will not have any symptoms. They may, however, have a flu-like illness within a month or two after exposure to the virus, with fever, headache, tiredness, and enlarged lymph nodes (glands of the immune system easily felt in the neck and groin). These symptoms usually disappear within a week to a month and are often mistaken for those of other viral infections. During this period, people are very infectious, and HIV is present in large quantities in blood, semen, and vaginal fluids.

Because there is no cure or vaccine to prevent HIV, the only way people can prevent infection from the virus is to avoid high-risk behaviors putting them at risk of infection, such as having unprotected sex or sharing needles. NIAID urges everyone ages 13 to 64 to get tested for HIV as part of their routine health care. Catching HIV in its early stages can make a lifesaving difference.

Treatment as prevention (TasP) refers to HIV prevention methods that use antiretroviral treatment (ART) to decrease the risk of HIV transmission. ART reduces the HIV viral load in the blood, semen, vaginal fluid and rectal fluid to very low levels ('undetectable'), reducing an individual's risk of HIV transmission 

In 1987, a drug called AZT became the first approved treatment for HIV disease. Since then, approximately 30 drugs have been approved to treat people living with HIV/AIDS, and more are under development. including:

·         "The Cocktail"

·         Antiretrovirals (ARVs)

·         Highly Active Antiretroviral Therapy (HAART or ART)

There are currently five different "classes" of HIV drugs. Each class of drug attacks the virus at different points in its life cycle—so if you are taking HIV meds, you will generally take 3 different antiretroviral drugs from 2 different classes.  This regimen is standard for HIV care—and it’s important. That’s because no drug can cure HIV, and taking a single drug, by itself, won’t stop HIV from harming you. Taking 3 different HIV meds does the best job of controlling the amount of virus in your body and protecting your immune system.

TREATMENT AND CARE PROGRAMS

Federal programs for the care and treatment of people with HIV

Ryan white HIV/AIDS program

Substance abuse & mental health programs 

AIDS statistics:

More than 1.2 million people in the United States are living with HIV infection, and almost 1 in 7 (14%) are unaware of their infection. CDC estimates that 1,201,100 persons aged 13 years and older are living with HIV infection, including 168,300 (14%) who are unaware of their infection. Over the past decade, the number of people living with HIV has increased, while the annual number of new HIV infections has remained relatively stable. In 2010, there were an estimated 47,500 new HIV infections.

In 2013, the estimated number of diagnoses of HIV infection in the United States was 47,352. There were 37,887 diagnoses in adult and adolescent males and 9,278 in adult and adolescent females. There were an estimated 187 diagnoses of HIV infection among children aged less than 13 years at diagnosis.

An estimated 13,712 people with an AIDS diagnosis died in 2012, and approximately 658,507 people in the United States with an AIDS diagnosis have died overall.

HIV Cure

There is no cure for HIV or AIDS, which means no procedure or medication which has been scientifically proven to reliably eliminate the virus from a person's body or reverse the damage to the immune system.

NIAID supports a large portfolio of investigator-initiated grants in HIV cure research to identify where HIV hides, known as the HIV reservoir, and to determine how these hideouts are established and maintained. In addition, NIAID also funds research to control and eliminate the viral reservoir.

 A possible “functional cure” for HIV has recently been granted FDA approval for further human testing. The method uses genetic modification to cause a specific mutation in the white blood cells of HIV patients which mirrors those found in the naturally immune. It has so far shown to be both receptive and long-lasting.

The International Conference on HIV/AIDS, STDs & STIs  which was recently held during October 24-25, 2013 at Holiday Inn Orlando International Airport, USA has received an overwhelming and immense participation from scientists, researchers, young researchers and foremost, the Editorial Members of OMICS Group Journals.

The conference was marked by the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 18 countries, who have driven this event into the path of success. The conference highlighted through various sessions and workshops on HIV/AIDS.

Special thanks to the honorable guests as the conference was set in motion with a warm welcome note from Jiang Yan, National Center for AIDS/STD Control and Prevention, China CDC, Geoffrey W. Hoffmann, Network Immunology Inc., Canada, Huynh Vu, Genomeplex Research Institute.GRI, USA.

On October 24^th,  the conference moved on with Keynote-presentations which remained as one of the highlights and were put forward by:

Daniel Bauer, Motivational Speaker and Activist, USA
Vladimir Zajac, Slovak Academy of Sciences, Slovakia
Gregory J. Tobin, Biological Mimetics, Inc., USA
Jiang Yan, National Center for AIDS/STD Control and Prevention, China CDC
Geoffrey W. Hoffmann, Network Immunology Inc., Canada

OMICS Group has taken the privilege of felicitating STD-AIDS-2013 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures. Also the conference was featured with Workshops.

Workshop: A workshop on“Manufacturing of HIV-1 Real-Time PCR test kit, ED DNA-Availue, to support HIV/AIDS project in Vietnam” was headed by Huynh Vu, Genomeplex Research Institute, Inc. (GRI), USA.

The flawless contributions from the renowed  speakers Maria Jose Miguez, Florida International university, USA,  Pilar S. Horner, Michigan State University, USA, Safiya George Dalmida, CFAR, Emory University, USA, Mona Hassan, Case Western Reserve University, USA, Stela Halichidis, Ovidius University, Romania, Jiatong Zhou, CDC, China and many such  have unveiled the inquisitions from the  arena of HIV/AIDS which enthralled the delegates.

Conference proceedings

OMICS Group, on behalf of STD-AIDS-2013, congratulates the Best Poster awardees  Dr. Safiya George Dalmida, Emory University, Nell Hodgson School of Nursing, USA, Dr. Elucir Gir, University of Sao Paulo at Ribeirao Preto College of Nursing, Brazil, and Malataji S. P.S., University of Venda, South Africa  for their outstanding performance in the field of HIV/AIDS, STDs & STIs and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.   

Our warm gratitude to our Ad. Sponsor, Be the generation (To end the AIDS epidemic) and Media partners, ICAAP 11, Bentham Science, Medtube, Labroots.com for associating with the conference.

With the unique feedback from the conference, OMICS Group would like to announce the commencement of "2^nd International Conference on HIV/AIDS, STDs & STIS" which is to be held during October 27-29, 2014 at Las Vegas, USA.

HIV infection and AIDS have become a major worldwide public health problem. According to WHO approximately 35 million people worldwide living with HIV/AIDS in 2013, unaware of the outcomes. AIDS (acquired immunodeficiency syndrome) is a chronic, potentially life-threatening condition caused by the human immunodeficiency virus (HIV) which damages the immune system and, interferes with body's ability to fight the organisms that cause disease. HIV is Sexually transmitted diseases which spread by contact with infected blood or from mother to child transmission during pregnancy, childbirth or breast-feeding. It can take years before HIV weakens the immune system to the point that the person is infected with AIDS.

With the generous response and support received from the participants of  HIV/AIDS, STDs, & STIs International Conference. OMICS International proudly announces “3^rd International  Conference on HIV/AIDS, STDs & STIs.” which will be held during November  30-December  02,  Atlanta,  USA  The Theme of the conference is “Raising Global Awareness on STD/AIDS and Fighting the Stigma Surrounding the Disease”.

OMICS International Organizes 300 Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400 Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. 

Infection rates are high in Georgia and metro Atlanta. Georgia ranked 4^th in the number of new AIDS cases, 7^th in cumulative AIDS cases and 8^th in the number of persons living with AIDS in 50 states, Atlanta show more than 26,000 people living with HIV/AIDS, and more than 9,500 of these (37%) have diagnosed AIDS cases. Approximately in World 123235 members are associated to HIV/AIDS, 56657 countries wise, 80 city wise. Global HIV/AIDS market, including branded products and generics, was valued at $11.3 billion in 2010.  $11.8 billion in 2011 and increase at a 4.6% compound annual growth rate (CAGR) over the 2011-2016 forecast periods to reach $14.1 billion in 2016. Branded products to treat HIV/AIDS were worth nearly $10.7 billion in 2010 and should reach $11 billion in 2011. This sector is expected to reach $13.2 billion in 2016.For more

For more details on the relevant conferences, please click here

Thanks to all our wonderful speakers, delegates, and all the conference attendees contributed for the success of 2^nd International Conference on STD-AIDS organized by OMICS Group. Congratulations for the tremendous job. STD-AIDS-2014 Conference was our best ever!

With the trail of the success of our previous conference, OMICS Group hosted the 2^ndInternational Conference on HIV/AIDS, STDS & STIS during October 27-29, 2014 at Embassy Suites, Las Vegas, USA with the theme “Raising Global Awareness on STD/AIDS and Fighting the Stigma Surrounding the Disease” which was a great success where eminent keynote speakers from various reputed institutions with their resplendent presence addressed the gathering.

The conference was marked by the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 18 countries, who have driven this event into the path of success. The conference highlighted through various sessions and workshops on HIV/AIDS.

STD-AIDS-2014 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the fields of HIV/AIDS, STDs & STIs.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures. Also the conference was featured with Workshop.

Workshop: A workshop on “Strategies for supporting people living with HIV for coping with the stigma organized by Dr. Bernardino Geraldo Alves Souto from Federal University of Sao Carlos, Sao Paulo, Brazil”

STD-AIDS-2014 Organizing Committee would like to thank the Honorable Moderator of the conference, Daniel Bauer, Successor to the legendary escape artist Harry Houdini, USA who contributed a major part for the smooth functioning and success of this event. OMICS Group International would like to convey a warm gratitude to all Honorable guests and Keynote Speakers of STD-AIDS-2014:

·         Daniel Bauer, Successor to the legendary escape artist Harry Houdini, Motivational speaker, USA

·         Andrew D. Badley, Mayo Clinic, USA

·         Berthold Kepplinger, Karl Landsteiner Research Institute for Neurochemistry, Neuropharmacology, Neurorehabilitation and Pain Treatment, Austria

·         Halina Baran, Karl Landsteiner Research Institute for Neurochemistry, Neuropharmacology, Neurorehabilitation and Pain Treatment, Austria

·         Simona Claudia Cambrea, Ovidius University, Romania

·         Francois Villinger, Emory University School of Medicine, USA

OMICS Group, on behalf of STD-AIDS-2014 conference, congratulates the Best Poster presenters for their outstanding performance and appreciates all the participants who put their research at poster presentations and sincerely wish them every success in their future endeavours. Also, we would like to thank the Poster Competition Judges Francois Villinger, Emory University School of Medicine, USA and Daniel Bauer, Successor to the legendary escape artist Harry Houdini, Motivational speaker, USA for their valuable support and suggestions.

Best Poster Awardees at STD-AIDS-2014:

1. Kledoaldo Olivera de Lima, Federal University of Pernambuco, Brazil

2. Krista Jones, University of Illinois College of Nursing, USA

3. Ying Zhou, Shanghai Institute of Planned Parenthood Research, Shanghai, China

Conference proceedings

OMICS Group is privileged to felicitate STD-AIDS-2014 Organizing Committee andEditorial Board Members of Journal of AIDS and Clinical Research, Journal of Antiviral and Antiretrovirals, Virology and mycology Keynote Speakers, Chairs & Co-Chairs and also the Moderator of the conference whose support and efforts made the conference to move in the path of success.

With the enormous feedback and promising response from the participants and supporters of STD-AIDS-2014, OMICS Group is glad to announce the commencement of 3^rd International Conference on HIV/AIDS, STDs & STIs during November 30- December 02, 2015 at Atlanta, USA. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of HIV/AIDS.

1.        Kledoaldo Olivera de Lima, Federal University of Pernambuco, Brazil

Title: Molecular characterization of HIV-1 Infection in Northeast of Brazil reveals the presence of rare subtypes and distinct BF recombinants forms

2.        Krista Jones, University of Illinois College of Nursing, USA

Title: Adolescent perceptions of sexual health education transmitted via social media

3.        Ying Zhou, Shanghai Institute of Planned Parenthood Research, Shanghai, China

Title: The effect of integrated intervention for service providers on condom promotion in public STD clinics, Shanghai, China

It is the delegate's responsibility to investigate the visa requirements for USA and to apply for a visa, if necessary. Individuals requiring an official Letter of Invitation from the conference organizers can request one by email by writing to us at hiv-stds@conferenceseries.com. 

To receive a Letter of Invitation, delegates, accompanying persons/children, student/post-doc/youth delegates and exhibitors must first register for the conference, pay in full and submit any required supporting documents (if applicable) before a Letter of Invitation will be issued. Media representatives must first register for the conference, pay in full for any additional orders (if applicable), submit all required documents and get approval from the conference organizers before a Letter of Invitation can be issued. 

The registration fee minus a handling fee of USD 150 will be refunded after the conference if the visa was applied for in time and proof is shown that a visa could not be granted even though all requested documents were submitted. Refund requests must be made in writing and sent to the STD-AIDS 2015 Registration Department, by email, no later than August 30, 2015. 

All expenses incurred in relation to the conference are the sole responsibility of the delegate. The Letter of Invitation does not guarantee an entry visa to USA. However, the conference organizers will not directly contact embassies and consulates on behalf of delegates. 

The deadline for requesting a Letter of Invitation is one month before travelling to USA